Care
It is now being tested at Princess Alexandra Hospital in Brisbane.
The app-based programme, developed by Neuroscience Research Australia, helped reduce fall-related injuries by 20% in clinical trials.
The app has demonstrated 93% accuracy in a nationwide study involving nearly 1,800 seniors.
The company said it plans to develop its new Chai‑2 platform to design, from square one, completely new antibodies for viruses and cancer.
Data reveals that the people who are enrolling in Medicare Advantage have 50% more chronic conditions than people who are enrolling in Medicare fee-for-service, says Christie Teigland, Inovalon's VP of research science and advanced analytics.
The Microdose GLP-1Rx Program will offer low-dose GLP-1 prescriptions combined with behavioral coaching, clinical monitoring and medication management.
The new law bans the use of AI for mental health and therapeutic decision-making, but states it can be used for administrative and supplementary support services.
The company began trading on the NYSE in May and saw an increase in its stock price upon the news of its second-quarter earnings.
The company aims to help providers secure stable pricing and access products and services for patients seeking reproductive and sexual healthcare.
The company will use the funds to scale its reach within the U.S. and to expand access to its offerings globally.